DE3376570D1 - Interferon induction method - Google Patents

Interferon induction method

Info

Publication number
DE3376570D1
DE3376570D1 DE8383300269T DE3376570T DE3376570D1 DE 3376570 D1 DE3376570 D1 DE 3376570D1 DE 8383300269 T DE8383300269 T DE 8383300269T DE 3376570 T DE3376570 T DE 3376570T DE 3376570 D1 DE3376570 D1 DE 3376570D1
Authority
DE
Germany
Prior art keywords
induction method
interferon induction
interferon
induction
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE8383300269T
Other languages
German (de)
English (en)
Inventor
Angel Simeonov Galabov
Margarita Hristova Mastikova
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pharmachim DSO
Original Assignee
Pharmachim DSO
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmachim DSO filed Critical Pharmachim DSO
Application granted granted Critical
Publication of DE3376570D1 publication Critical patent/DE3376570D1/de
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE8383300269T 1982-01-19 1983-01-19 Interferon induction method Expired DE3376570D1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
BG8255032A BG36086A1 (en) 1982-01-19 1982-01-19 Method for inducing interferon

Publications (1)

Publication Number Publication Date
DE3376570D1 true DE3376570D1 (en) 1988-06-16

Family

ID=3910170

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8383300269T Expired DE3376570D1 (en) 1982-01-19 1983-01-19 Interferon induction method

Country Status (6)

Country Link
US (1) US4499093A (ja)
EP (1) EP0084953B1 (ja)
JP (1) JPS58170715A (ja)
BG (1) BG36086A1 (ja)
DE (1) DE3376570D1 (ja)
HU (1) HU192123B (ja)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2470599A1 (fr) * 1979-12-07 1981-06-12 Panoz Donald Perfectionnements apportes aux procedes de preparation de formes galeniques a action retard et a liberation programmee et formes galeniques de medicaments ainsi obtenus
AU622104B2 (en) * 1987-03-11 1992-04-02 Sangtec Molecular Diagnostics Ab Method of assaying of nucleic acids, a reagent combination and kit therefore
EP0295317A1 (en) * 1987-06-16 1988-12-21 BOEHRINGER INGELHEIM INTERNATIONAL GmbH Pharmaceutical composition for the treatment of tumors
US5215744A (en) * 1987-06-16 1993-06-01 Boehringer Ingelheim Gmbh Methods for the treatment of tumors
GB8813032D0 (en) * 1988-06-02 1988-07-06 Boehringer Ingelheim Int Antiviral pharmaceutical composition
US7253155B2 (en) * 2001-10-05 2007-08-07 Combinatorx, Inc. Combinations for the treatment of immunoinflammatory disorders
TW200517114A (en) * 2003-10-15 2005-06-01 Combinatorx Inc Methods and reagents for the treatment of immunoinflammatory disorders
US20090075955A1 (en) * 2007-09-19 2009-03-19 Combinatorx, Inc. Therapeutic regimens for the treatment of immunoinflammatory disorders
NZ586332A (en) * 2007-12-17 2012-07-27 Zalicus Inc Therapeutic regimens for the treatment of immunoinflammatory disorders using dipyridamole and prednisolone

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DD116752A1 (ja) * 1974-03-25 1975-12-12

Also Published As

Publication number Publication date
BG36086A1 (en) 1984-09-14
JPS58170715A (ja) 1983-10-07
HU192123B (en) 1987-05-28
US4499093A (en) 1985-02-12
EP0084953B1 (en) 1988-05-11
EP0084953A1 (en) 1983-08-03

Similar Documents

Publication Publication Date Title
DE3472045D1 (en) Induction motors
YU162281A (en) Process for obtaining interferon
PL242971A1 (en) Antiphlogistine obtaining method
DE3371587D1 (en) Linear induction pump
GB2113510B (en) Induction coil
GB8306712D0 (en) Pulse-counting method
GB8332072D0 (en) Currency-dispensing method
EG15337A (en) Induction logging technique
EP0115178A3 (en) Digital controller
ZA815103B (en) Induction motor
GB2122446B (en) Induction cooking apparatus
DE3376570D1 (en) Interferon induction method
GB8314400D0 (en) Interferon production
GB8308594D0 (en) Curved ceiling-building method
GB2135538B (en) Inductive heating apparatus
GB8423247D0 (en) Interferon
GB2123835B (en) Interferon e
DE3473082D1 (en) Electromagnetic induction apparatus
GB2089583B (en) Induction motors
GB8320259D0 (en) Positioning method
GB8402737D0 (en) Electrical induction apparatus
GB2137426B (en) Inductive apparatus
GB2118475B (en) Slip-casting method
BG49678A1 (en) Induction vacuum electro- furnace
ZA84915B (en) Inductive apparatus

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee